* These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, mitigate or prevent any disease. OTC GH-2000 is produced according to the guidelines of the HPUS
|
|
3-F-97-258 |
Fatigue |
PD |
44 |
F |
1/13/97 |
167ng/ml |
2/12/97 |
186ng/ml |
+19 |
11% |
2 |
3-M-97-258 |
Over Weight |
PD |
41 |
M |
1/13/97 |
206ng/ml |
2/11/97 |
280ng/ml |
+79 |
36% |
3 |
3-M-97-259 |
Severe Fatigue |
RL |
47 |
M |
1/17/97 |
174ng/ml |
2/20/97 |
185ng/ml |
+11 |
6% |
1 |
3-F-97-261 |
Depression |
JK |
37 |
F |
1/17/97 |
201ng/ml |
2/21/97 |
271ng/ml |
+70 |
35% |
3 |
3-F-97-263 |
Hormonal |
RL |
39 |
F |
1/20/97 |
212ng/ml |
2/24/97 |
286ng/ml |
+74 |
35% |
3 |
3-F-97-264 |
Depression |
JK |
45 |
F |
1/20/97 |
119ng/ml |
2/24/97 |
159ng/ml |
+40 |
34% |
3 |
3-M-97-265 |
Fatigue |
PD |
60 |
M |
1/20/97 |
142ng/ml |
2/27/97 |
190ng/ml |
+48 |
31% |
3 |
3-M-97-267 |
Over Weight |
RL |
56 |
M |
1/24/97 |
122ng/ml |
4/16/97 |
223ng/ml |
+101 |
83% |
4 |
3-F-97-268 |
Depression |
JK |
62 |
F |
1/24/97 |
146ng/ml |
2/26/97 |
192ng/ml |
+46 |
31% |
3 |
3-F-97-271 |
Insomnia |
HL |
37 |
F |
1/27/97 |
214ng/ml |
2/25/97 |
290ng/ml |
+76 |
36% |
3 |
3-M-97-272 |
Fatigue |
PD |
32 |
M |
1/27/97 |
204ng/ml |
3/27/97 |
228ng/ml |
+24 |
13% |
2 |
3-M-97-274 |
Severe Fatigue |
PD |
53 |
M |
1/31/97 |
41ng/ml |
2/25/97 |
160ng/ml |
+119 |
290% |
4 |
3-M-97-275 |
Hormonal |
RL |
38 |
M |
1/31/97 |
139ng/ml |
3/3/97 |
238ng/ml |
+99 |
71% |
3 |
3-F-97-276 |
Fatigue |
PD |
48 |
F |
1/31/97 |
140ng/ml |
2/24/97 |
171ng/ml |
+31 |
22% |
3 |
3-F-97-277 |
Arthritis |
RL |
50 |
F |
2/3/97 |
96ng/ml |
3/7/97 |
143ng/ml |
+47 |
49% |
3 |
4-F-97-278 |
Arthritis |
RL |
40 |
F |
2/3/97 |
184ng/ml |
3/5/97 |
261ng/ml |
+77 |
42% |
3 |
4-F-97-230 |
Fatigue |
PD |
60 |
F |
2/7/97 |
51ng/ml |
3/5/97 |
110ng/ml |
+59 |
116% |
4 |
4-F-97-231 |
Over Weight |
RL |
49 |
F |
2/7/97 |
113ng/ml |
3/12/97 |
152ng/ml |
+39 |
35% |
3 |
4-M-97-232 |
Depression |
JK |
57 |
M |
2/7/97 |
121ng/ml |
3/3/97 |
186ng/ml |
+65 |
54% |
3 |
4-M-97-235 |
Depression |
JK |
50 |
M |
2/10/97 |
162ng/ml |
3/14/97 |
181ng/ml |
+19 |
12% |
2 |
4-F-97-237 |
Depression |
JK |
38 |
F |
2/10/97 |
133ng/ml |
3/10/97 |
124ng/ml |
-9 |
-7% |
|
4-M-97-238 |
Fatigue |
PD |
48 |
M |
2/10/97 |
128ng/ml |
5/21/97 |
197ng/ml |
+69 |
54% |
3 |
4-M-97-239 |
Hormonal |
RL |
42 |
M |
2/14/97 |
207ng/ml |
3/12/97 |
248ng/ml |
+41 |
20% |
3 |
4-M-97-240 |
Fatigue |
PD |
51 |
M |
2/14/97 |
42ng/ml |
3/18/97 |
96ng/ml |
+54 |
129% |
4 |
4-M-97-241 |
HIV |
AP |
32 |
M |
2/17/97 |
224ng/ml |
3/20/97 |
255ng/ml |
+31 |
14% |
2 |
4-F-97-242 |
HIV |
AP |
45 |
F |
2/17/97 |
144ng/ml |
3/18/97 |
215ng/ml |
+71 |
49% |
3 |
4-M-97-244 |
Severe Fatigue |
PD |
57 |
M |
2/21/97 |
101ng/ml |
4/2/97 |
174ng/ml |
+73 |
72% |
3 |
4-F-97-248 |
Depression |
JK |
62 |
F |
2/24/97 |
98ng/ml |
3/25/97 |
157ng/ml |
+59 |
60% |
3 |
4-M-97-249 |
Over Weight |
RL |
65 |
M |
2/24/97 |
47ng/ml |
3/27/97 |
102ng/ml |
+55 |
117% |
4 |
4-F-97-250 |
Over Weight |
RL |
51 |
F |
2/28/97 |
113ng/ml |
4/1/97 |
161ng/ml |
+48 |
42% |
3 |
4-F-97-253 |
Arthritis |
RL |
39 |
F |
3/3/97 |
219ng/ml |
4/8/97 |
241ng/ml |
+22 |
10% |
2 |
4-F-97-257 |
Fatigue |
PD |
47 |
F |
3/7/97 |
185ng/ml |
4/10/97 |
214ng/ml |
+29 |
16% |
2 |
4-F-97-260 |
Hormonal |
RL |
55 |
F |
3/10/97 |
95ng/ml |
4/15/97 |
144ng/ml |
+49 |
52% |
3 |
4-M-97-261 |
Fatigue |
PD |
33 |
M |
3/10/97 |
129ng/ml |
4/11/97 |
187ng/ml |
+58 |
45% |
3 |
4-F-97-264 |
Insomnia |
HL |
39 |
F |
3/14/97 |
104ng/ml |
4/18/97 |
153ng/ml |
+49 |
47% |
3 |